Hypertension is a disease, which if left untreated affects all important organs of human body. It is known as silent killer as without showing significant symptoms, it may quietly lead to stroke, brain hemorrhage, cardiac disorders, renal failure and vision loss. Hypertension has affected 10-15% of global population and killed a large number of human race in every region of world. Drugs used for its treatment on one hand are very expensive and beyond the reach of a common man while on the other hand, side effects associated with these drugs restricted the people to use them. Hence development of a cost effective antihypertensive drug with minimum or no side effects from commonly available indigenous medicinal plants is highly required. Keeping this in view as well as blood pressure reducing property of Bombax ceiba present work describes the hypotensive evolution of its stem bark alongwith toxicology and histopathology of active fraction.
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Bombax ceiba (syn. Bombax malabaricum DC) commonly known as silk cotton tree is an important medicinal plant. 1, 2) Earlier investigations led to the identification of a sesquiterpene lactone, a potent growth inhibitor in fungi 3) and a flavonol glycoside possessing significant hypotensive and hypoglycaemic activities. 4) Both of these compounds were isolated from roots and leaves of B. ceiba respectively. This is the first report of hypotensive evaluation of it's stem bark which has resulted in the isolation of a novel benzopyran dimer, shamimicin, lupeol 5) and fractions possessing hypotensive activity. In addition to this, methanolic extracts of different parts of plant, including flowers, pulp, stem and stem bark have also been studied for their effect on mean arterial blood pressure (MABP) of rats.
MATERIALS AND METHODS
Instrumentation Ultraviolet spectra were recorded in MeOH on Hitachi-U-3200 and infrared spectra were measured in CHCl 3 on JASCO-A-302 spectrophotometers. The electron impact (EI) mass spectra were recorded on a Finnigan MAT-112 instrument. Field desorption (FD-MS), fast atom bombardment (FAB-MS positive and negative) and exact mass measurements were carried out on a Finnigan MAT-312 instrument. High-resolution mass spectra were recorded on a JMS HX-110 spectrometer. Acetylation of Lupeol A solution of lupeol (50 mg) in pyridine (0.5 ml) was treated with acetic anhydride (0.5 ml) and left over night at room temperature. Reaction mixture when evaporated under hood gave white needles. Needles obtained from bottom of flask were recrystallized with CHCl 3 -MeOH, which gave pure white bunch of needles [35 mg, mp 214°C, lit. mp 215-216°C 6) ]. Isolation of Novel Shamimicin Marc left after the extraction of B. ceiba stem bark with petroleum ether was extracted successively with methanol (thrice) and 50% aqueous methanol. Combined methanolic extracts and 50% methanolic extract were evaporated under reduced pressure to give concentrated mass BCBM (41.3 g) and BCBM-50 (31.2 g). A solid matter settled at the bottom of flask containing BCBM when kept in cold for three days. It was filtered to give soluble (BCBMM, 36.5 g) and insoluble fraction (BCBMI, 4.5 g).
Vacuum liquid chromatography (VLC) of BCBMM [silica gel 60 GF 254 260 g, using petroleum ether (PE, 2.7 l), ethyl acetate (EA, 5.5 l), methanol (6.8 l) and water (1.9 l) with gradually increasing polarity by 10%, volume eluted 500 ml] gave 35 fractions. Animals and Drugs Animals used in this study were Sprague-Dawley rats (200-250 g) and NMRI mice (20-30 g). They were housed at the Animal House of Dr. HMI Institute of Pharmacology and Herbal Sciences, Hamdard University and were given a standard diet and tap water ad-libitum. Drugs used were acetylcholine and sodium chloride from E. Merck, tween 80 from BDH chemicals, atropine sulfate from Boehringer Ingelheim, and Pentothal ® sodium from Abbott Karachi. Acetylcholine (1 mg/kg) was used as a positive control while saline (0.9% NaCl) and 10% tween-80 (in the case of BCBP, lupeol and its acetate) as negative controls.
Hypotensive Activity Normotensive Sprague-Dawley rats (either sex, 200-250 g) were anaesthetized with pentothal ® sodium (50 mg/kg i.p.). The trachea was exposed and cannulated to facilitate spontaneous respiration. Drugs were injected (vol. 0.2-0.25 ml) through a polyethylene cannula inserted into the external jugular vein followed by a saline flush (0.2 ml). The arterial blood pressure was recorded from the carotid artery via polyethylene arterial cannula connected to a Research Grade Blood Pressure Transducer (Harvard, 60-3003) coupled with four channel Harvard Universal Oscillograph (Curvilinear, 50-9307). The temperature of the animals was maintained at 37°C by use of over head lamp. Animals were allowed to equilibrate for at least 15 min before administration of any drug. Mean arterial blood pressure (MABP) was calculated as sum of the diastolic blood pressure plus one-third pulse width. Changes in blood pressure were expressed as the percent of control values, obtained immediately before the administration of test substance.
4)
Hypotensive Activity of BCBMM through Oral Route Two groups of three male rats in each group were taken. Group-I treated (p.o.) with BCBMM at the dose of 200 mg/kg/d for five consecutive days. Group-II serving as control was treated with saline. On fifth day after two hours of last dose, all animals were anaesthetized with pentothal ® sodium (25 mg/kg, i.p.) and cannulated as described earlier.
Toxicology Acute toxicity of BCBMM was measured in mice (20-30 g) by oral route of administration. Three sets of each containing 10 mice (males and female) were taken. Group-1 and II were treated with 100 mg/kg/g and 1000 mg/kg/d (vol. of each dose was 0.7-0.8 ml) of BCBMM respectively for seven consecutive days. 4) Group-III served as control, and was given saline. All the animals were kept under constant observation for two hours to observe any change in general behavior or other physical activities. Numbers of survivors were noted after seven days. Survived mice were killed by hitting on the head for tissue analysis. Heart, liver and kidneys of killed as well as freshly dead animals were removed, blotted and weighed immediately on electronic balance.
Histology Heart, liver and kidneys were fixed in 10% formalin. After usual processes of dehydration, clearing and infiltration, tissues were embedded in paraffin wax and sectioned into 5-mm slices through Leica RM 2145-Rotation Microtom. The tissues were stained with haematoxylin and eosin. The slides were studied and photographed through Nikon Advance Trinocular Research Microscope OP-TIPHOT Model X2T-21E equipped with Nikon Microphotography system; Model UFX-DX-35 and phase contrast N plan.
Statistical Analysis Changes in blood pressure and weights of vital organs were compared using analysis of variance followed by Student's t-test. Values of pϽ0.01, pϽ0.001 were considered to be significant.
RESULTS AND DISCUSSION
Petroleum ether extract of B. ceiba stem bark (BCBP) caused 58% fall in MABP of rats at the dose of 10 mg/kg. In some cases third administration of the same dose (after 20-30 min of last administration) caused death of rat. Lupeol the main component (30%) of non polar extract and an anti-inflammatory agent 9) exhibited 44% and 52% reduction in blood pressure for 1.7Ϯ0.6 min and 2.8Ϯ1.8 min at the dose of 5 mg/kg and 15 mg/kg respectively. This is the second report of hypotensive activity of lupeol. Earlier lupeol from Acosmium dasycarpum was reported to decrease blood pressure at 20-100 mg/kg. 10) Lupeol acetate, an anti-inflammatory triterpene 9) exhibited 43% fall in MABP at 3 mg/kg for 1.8Ϯ1.1 min. Derivative did not show any significant effect at 1 mg/kg. BCBP and lupeol were not completely soluble in 10% tween-80 and some residue remained settled at the bottom of vial. Since lupane type of triterpenes have reported to posses hepatoprotective, 11) anti-HIV 12) and tumor growth inhibitory 13) properties, lupeol which constitutes 0.06% of plant's stem bark can also be studied for similar type of activities.
Methanolic extract of defatted stem bark (BCBM) and its fraction BCBMI produced 30% and 51-57% hypotension at 10 mg/kg and 30 mg/kg respectively ( Table 1 ). The 50% methanolic extract (BCBM-50) at both doses of 10 mg/kg and 30 mg/kg showed 17-20% fall in MABP, comparatively low intensity of action for 1.7Ϯ1.2 min and 2.2Ϯ1.2 min respectively. BCBMM-the other fraction of BCBM, showed hypotensive effect of 31% and 65% at the dose of 3 mg/kg and 15 mg/kg. Hypotensive action of BCBMM lasted for 1.6Ϯ0.2 min and 3.7Ϯ1.1 min respectively at corresponded doses. VLC of BCBMM resulted in highly potent fractions BA, BC and BD, moderately active BE and inactive fraction BB (Table 1) . BC and BD showed comparable potency of hypotension but the effect of BC lasted for more than 2 min. Duration of activity in rest of the fractions was mostly less than one minute (Table 1) .
Shamimicin, a new rarely occurring glycoside caused no significant fall in blood pressure at the dose of 15 mg/kg. Shamimicin is a dimeric ent-epicatechin glycoside (vide structure). Since ent-epicatechins are known to possess cardiac stimulating, hyperglycaemic, hypoglycaemic 14) hair growth promoting 15) and antioxidant activities, 16) it is possible that shamimicin might possess activity at higher doses. The detailed spectroscopy and elucidation of structure for shamimicin is submitted for publication elsewhere.
BCBM and BCBM-50 did not exhibit their hypotensive effect when examined in rats pretreated with atropine sulfate (69.5 mg/kg). This behavior matches exactly to that of acetyl choline (1 mg/kg), which did not produce, any fall in blood pressure in the presence of atropine sulfate. It may therefore be concluded that muscarinic M 2 receptors on cardiac muscles as well as vascular dilation by endothelium derived relaxing factor may contribute to the cholinergic hypotensive effect of BCBM and BCBM-50. Conversely, hypotensive property of BCBMM remained unaltered in atropinized rats. Rest of the constituents could not examined due to paucity of compound or shortage of experimental animals.
Methanolic extract of flowers (BCF) and pulp (BCP) were found as most active hypotensive agents among methanolic extracts of different parts of plant. They showed comparable 50% reduction in blood pressure with maximum duration of effect at 30 mg/kg. Methanolic extract of stem bark (BCB) is found more active than stem (BCS) ( Table 2 ). In each of these extracts activity lasted for 1-3 min (Table 2) .
Acetylcholine used as positive control caused 58.3Ϯ3.1% (meanϮS.E.M., nϭ4) fall in mean arterial blood pressure at the dose of 1 mg/kg. Solvents (saline and 10% tween-80) used as negative control did not cause any significant change in blood pressure of rat. Hypotensive Activity of BCBMM through Oral Route Animals treated orally with BCBMM at the dose of 200 mg/kg/d showed MABP at 105.3Ϯ2.8 mmHg while that of control was found at 121.3Ϯ1.2 mmHg. Hence drug caused 13.2% reduction of MABP by oral route which is significant as pϽ0.01.
Toxicology BCBMM caused expiry of two male and one female mice at the dose of 100 mg/kg/d. Male mice showed 17% loss in body weight while female mice showed comparatively less reduction of only 7%. None of these mice showed any change in their physical activities. At 1000 mg/kg/d, all five male mice were expired just after two doses. Females were more resistant and last female mice died after six doses. All these animals become inactive after first dose and some adopted statue like position before death. Control group did not show any mortality or significant change in their general behavior or physical activities.
Tissue Analysis Three of mice died as a result of oral administration of BCBMM at 1000 mg/kg/d, showed 67% increase in weight as compared to control liver. Colour of liver got fade and light yellow patches were clearly seen. Heart and kidneys did not show any morphological change, but their weights were significantly increased by 7% and by 19% respectively as compared to control values (Table 3) .
Histopathology Heart Nuclei seems to be disintegrated or disappeared. Muscle fiber architecture was disturbed and areas of cellular infiltration were also present (Figs. 1, 2) .
Liver Most of the hepatocytes were swollen, hydropic (ballooning degeneration) and often binucleated (Figs. 3, 4) . The condition indicates that BCBMM might have caused liver cell necrosis resulting in liver cell derangement.
Kidneys Cortical region was full of fibrous and granular tissues. Most of the proximal and distal convulated tubules were destructed. The adjacent tubules were separated from 44 Vol. 26, No. 1 one another by edematous interstitial tissue (Figs. 5, 6 ). Glomerular architecture appeared disturbed. There is patchy diffuse infiltration of glomerular tuft with eosinophilic material and is fibrinoid in appearance (Fig. 7) . In medullary region of kidney the architecture of papillary ducts and loop of Henle (thick and thin segment) appeared disturbed while lining epithelium of papillary ducts showed necrosis (Figs. 8,  9 ).
CONCLUSION
Lupeol and fraction BCBMM have emerged as potent hypotensive constituents of Bombax ceiba stem bark while new dimeric glycoside shamimicin was found devoid of any activity at the dose of 15 mg/kg. Intravenous administration of 15 mg/kg of BCBMM caused 65% fall in blood pressure of rats for 4 min. While oral administration of 200 mg/kg/d for five days showed significant hypotension of 13.18%. Low percentage of hypotension (though significant) at higher dose of 200 mg/kg/d through oral route as compared to intravenous administration indicates that active ingredient of BCBMM has low absorbance in blood either due to its very hydrophilic nature or biotransformation. Chemical and pharmacological evaluation of BCBMM (which is underprogress) may lead to active constituents which might be able to show significant bioavailability. Toxicology of BCBMM determined 1000 mg/kg/d as lethal dose (LD 100 ) killing all mice by affecting their vital organs including heart, kidneys and liver. Dose at 100 mg/kg/d is also not safe in mice as it caused expiry of three animals. It is interesting to note that 200 mg/kg/d of BCBMM did not show any mortality in rats, although sample size was quite small (only three). Hence it may be assumed that low doses of BCBMM (smaller than 100 mg/kg) can be useful in reducing blood pressure safely. However, in order to determine exact effective and safe dose of BCBMM, some more experiments in different species of animals at different doses are required.
